Multiple inherent response patterns to transplantation antigens

Current Opinion in Organ Transplantation

Volumn 10, Issue 1, 2005, Pages 15-19

  Ichim, Thomas E ^a   Wang, Hao ^a   Zhong, Robert ^a,b,c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Genetics; Mouse; Rejection; Transplantation

Indexed keywords

ANTIGEN; CYCLOSPORIN; CYTOKINE; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; PROSTAGLANDIN E2; RAPAMYCIN;

ACUTE GRAFT REJECTION; ALLOGRAFT; BREEDING; CLINICAL PROTOCOL; CYTOKINE PRODUCTION; FIBROSIS; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOMICS; HISTOCOMPATIBILITY; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INDIVIDUALIZATION; LEISHMANIASIS; MOUSE STRAIN; NONHUMAN; ORGAN DONOR; ORGAN TRANSPLANTATION; PHARMACOGENOMICS; RECIPIENT; REVIEW; SIDE EFFECT; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE INJURY; XENOGRAFT;

EID: 17344366052     PISSN: 10872418     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Biozzi G, Stiffel C, Mouton D, et al. Cytodynamics of the immune response in two lines of mice genetically selected for 'high' and 'low' antibody synthesis. J Exp Med 1972; 135:1071.
2. Covelli V, Mouton D, Di Majo V, et al. Inheritance of immune responsiveness, life span, and disease incidence in interline crosses of mice selected for high or low multispecific antibody production. J Immunol 1989; 142:1224.
3. Araujo LM, Puel A, Gouarin C, et al. NKT lymphocyte ontogeny and function are impaired in low antibody-producer Biozzi mice: gene mapping in the interval-specific congenic strains raised for immunomodulatory genes. Int Immunol 2000; 12:1613.
4. Appleyard G, Wilkie BN, Kennedy BW, Mallard BA. Antibody avidity in Yorkshire pigs of high and low immune response groups. Vet Immunol Immunopathol 1992; 31:229.
5. Jayagopala Reddy NR, Wilkie BN, Borgs P, Mallard BA. Cytokines in Mycoplasma hyorhinis-induced arthritis in pigs bred selectively for high and low immune responses. Infect Immun 2000; 68:1150.
6. Bradley DJ. Genetic control of natural resistance to Leishmania donovani [letter]. Nature 1974; 250:353.
7. Wrightsman R, Krassner S, Watson J. Genetic control of responses to Trypanosoma cruzi in mice: multiple genes influencing parasitemia and survival. Infect Immun 1982; 36:637.
8. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7:145.
9. Constant SL, Bottomly K. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu Rev Immunol 1997; 15:297.
10. Sadick MD, Heinzel FP, Holaday BJ, et al. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody: evidence for a T cell-dependent, interferon gamma-independent mechanism. J Exp Med 1990; 171:115.
11. Hsieh CS, Macatonia SE, O'Garra A, Murphy KM. T cell genetic background determines default T helper phenotype development in vitro. J Exp Med 1995; 181:713.
12. Su SH, Chen H, Jen CJ. C57BL/6 and BALB/c bronchoalveolar macrophages respond differently to exercise. J Immunol 2001; 167:5084.
13. Mills CD, Kincaid K, Alt JM, et al. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 2000; 164:6166.
14. Filippi C, Hugues S, Cazareth J, et al. CD4+ T cell polarization in mice is modulated by strain-specific major histocompatibility complex-independent differences within dendritic cells. J Exp Med 2003; 198:201.
15. Kuroda E, Sugiura T, Zeki K, et al. Sensitivity difference to the suppressive effect of prostaglandin E2 among mouse strains: a possible mechanism to polarize Th2 type response in BALB/c mice. J Immunol 2000; 164: 2386.
16. Guler ML, Gorham JD, Hsieh CS, et al. Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development. Science 1996; 271:984.
17. Beebe AM, Mauze S, Schork NJ, Coffman RL. Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice. Immunity 1997; 6:551.
18. Liu T, Matsuguchi T, Tsuboi N, et al. Differences in expression of toll-like receptors and their reactivities in dendritic cells in BALB/c and C57BL/6 mice. Infect Immun 2002; 70:6638.
19. Doyle SE, O'Connell RM, Miranda GA, et al. Toll-like receptors induce a phagocytic gene program through p38. J Exp Med 2004; 199:81.
20. Asea A, Rehli M, Kabingu E, et al. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 2002; 277:15028.
21. Taylor KR, Trowbridge JM, Rudisill JA, et al. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 2004; 279: 17079.
22. Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 2001; 167:2887.
23. Shi Z, Wakil AE, Rockey DC. Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. Proc Natl Acad Sci U S A 1997; 94:10663.
24. Bhathal PS, Jordan TW, Mackay IR. Mouse strain differences in susceptibility to sporidesmin-induced biliary tract injury. Liver 1990; 10:193.
25. Gur I, Or R, Segel MJ, et al. Lymphokines in bleomycin-induced lung injury in bleomycin-sensitive C57BL/6 and -resistant BALB/c mice. Exp Lung Res 2000; 26:521.
26. Ortiz LA, Lasky J, Hamilton RF Jr, et al. Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice. Exp Lung Res 1998; 24:721.
27. Kolb M, Bonniaud P, Galt T, et al. Differences in the fibrogenic response after transfer of active transforming growth factor-beta1 gene to lungs of 'fibrosis-prone' and 'fibrosis-resistant' mouse strains. Am J Respir Cell Mol Biol 2002; 27:141.
28. Erickson AC, Barcellos-Hoff MH. The not-so innocent bystander: the microenvironment as a therapeutic target in cancer. Expert Opin Ther Targets 2003; 7:71.
29. Ludviksson BR, Seegers D, Resnick AS, Strober W. The effect of TGF-beta1 on immune responses of naive versus memory CD4+ Th1/Th2 T cells. Eur J Immunol 2000; 30:2101.
30. Borsutzky S, Cazac BB, Roes J, Guzman CA. TGF-beta receptor signaling is critical for mucosal IgA responses. J Immunol 2004; 173:3305.
31. Bommireddy R, Doetschman T. TGF-beta, T-cell tolerance and anti-CD3 therapy. Trends Mol Med 2004; 10:3.
32. Wang H, DeVries ME, Deng S, et al. The axis of interleukin 12 and gamma interferon regulates acute vascular xenogeneic rejection. Nat Med 2000; 6:549.
33. Wang H, Hosiawa KA, Min W, et al. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting. J Immunol 2003; 171:3823.
34. Nathan MJ, Mold JE, Wood SC, et al. Requirement for donor and recipient CD40 expression in cardiac allograft rejection: induction of Th1 responses and influence of donor-derived dendritic cells. J Immunol 2004; 172: 6626.
35. Williams MA, Trambley J, Ha J, et al. Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts. J Immunol 2000; 165:6849.
36. Ojo AO, Port FK, Held PJ, et al. Inferior outcome of two-haplotype matched renal transplants in blacks: role of early rejection. Kidney Int 1995; 48: 1592.
37. Meier-Kriesche HU, Oio A, Magee JC, et al. African-American renal transplant recipients experience decreased risk of death due to infection: possible implications for immunosuppressive strategies. Transplantation 2000; 70:375.
38. Podder H, Podbielski J, Hussein I, et al. Sirolimus improves the two-year outcome of renal allografts in African-American patients. Transpl Int 2001; 14:135.
39. Hassan MI, Aschner Y, Manning CH, et al. Racial differences in selected cytokine allelic and genotypic frequencies among healthy, pregnant women in North Carolina. Cytokine 2003; 21:10.
40. Hutchinson IV, Pravica V, Perrey C, Sinnott P. Cytokine gene polymorphisms and relevance to forms of rejection. Transplant Proc 1999; 31:734-736.
41. Turner D, Grant SC, Yonan N, et al. Cytokine gene polymorphism and heart transplant rejection. Transplantation 1997; 64:776-779.
42. Thomas FJ, McLeod HL, Watters JW. Pharmacogenomics: the influence of genomic variation on drug response. Curr Top Med Chem 2004; 4:1399.